Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration to Scale Human-Centric Drug Discovery

Greenstone Biosciences and Intel Partner to Advance Human-Centric Drug Discovery at Scale

Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration to Scale Human-Centric Drug Discovery Greenstone Biosciences, Inc. announces a collaboration with Intel Corp. to accelerate AI-enabled drug discovery using Greenstone’s large-scale, human biobank of induced pluripotent stem cells and Intel’s Edge AI advanced computing and AI infrastructure. Intel and Greenstone are working together…

Read MoreGreenstone Biosciences and Intel Partner to Advance Human-Centric Drug Discovery at Scale
Haypp

Haypp Group Critique Challenges Seizure Claims Linked to Nicotine Pouches in Animal Study

New Critique by Haypp Group Warns Seizure Claims About Nicotine Pouches Overstate Animal Study Findings Giving mice a chemically induced epileptic condition and then adding nicotine does not prove that nicotine causes or worsens seizures, according to Haypp Group’srecently published…

Read MoreHaypp Group Critique Challenges Seizure Claims Linked to Nicotine Pouches in Animal Study
IQM

IQM Names Former Illumina Executive Craig Ciesla as CTO, Appoints Inés de Vega Chief Scientist

IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist IQM Quantum Computers, the global leader in superconducting quantum computers, announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés…

Read MoreIQM Names Former Illumina Executive Craig Ciesla as CTO, Appoints Inés de Vega Chief Scientist
101 Therapeutics

101 Therapeutics Releases Clinical Data for 101-PGC-005 and Calls for Independent Review in Bundibugyo Ebola Disease

101 Therapeutics Releases Clinical Evidence Package for Macrophage-Targeted 101-PGC-005 and Seeks Urgent Independent Review for Bundibugyo Ebola Disease 101 Therapeutics Ltd. today announced the public release of its clinical and scientific evidence package for 101-PGC-005 (‘005), a macrophage-targeted dexamethasone prodrug…

Read More101 Therapeutics Releases Clinical Data for 101-PGC-005 and Calls for Independent Review in Bundibugyo Ebola Disease
Blooming Future Launches Operations as Part of Braskem’s Expanding Sustainable Fleet

Blooming Future Begins Operations, Expanding Braskem’s Sustainable Fleet Initiative

Blooming Future Launches Operations as Part of Braskem’s Expanding Sustainable Fleet Braskem the largest polyolefins producer in the Americas and global leader in the production of biopolymers on an industrial scale announces that Braskem Trading & Shipping (BT&S) has launched the…

Read MoreBlooming Future Begins Operations, Expanding Braskem’s Sustainable Fleet Initiative
Laprophan

Laprophan Finalizes Rivopharm Acquisition, Strengthening Global Growth and International Market Expansion

Laprophan Completes the Acquisition of Rivopharm, Accelerating Its International Expansion Strategy Laprophan Group, the pioneer and one of Morocco’s leading pharmaceutical groups, announced the successful completion of the acquisition of a controlling stake in Rivopharm, a Switzerland-based pharmaceutical company specialized in…

Read MoreLaprophan Finalizes Rivopharm Acquisition, Strengthening Global Growth and International Market Expansion
Real Chemistry

Real Chemistry Unifies Omnichannel Services Under Real Chemistry Media

Real Chemistry Unifies Omnichannel Offering as Real Chemistry Media, a Technology-led, Healthcare-focused Practice of the Future Real Chemistry, a leader in AI-driven insights and marketing and communications exclusively for the healthcare and life sciences sectors, announced the full integration of…

Read MoreReal Chemistry Unifies Omnichannel Services Under Real Chemistry Media
CareDx Presents

CareDx Presents Extensive Precision Medicine Research at the 2026 American Transplant Congress

CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress CareDx, Inc. The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value…

Read MoreCareDx Presents Extensive Precision Medicine Research at the 2026 American Transplant Congress
Nomic

Nomic and Wellcome Sanger Institute Partner to Advance Protein-Level Insights into Immune Diversity Genetics

Nomic and Wellcome Sanger Institute Collaborate to Bring Protein-Level Resolution to the Genetics of Immune Diversity Nomic Bio Inc. announced a research collaboration with the Wellcome Sanger Institute to perform large-scale proteomic profiling of human-derived peripheral blood mononuclear cell (PBMC)…

Read MoreNomic and Wellcome Sanger Institute Partner to Advance Protein-Level Insights into Immune Diversity Genetics
Osmo

Osmo to Auction 10 Proprietary AI-Created Fragrance Ingredients

Osmo To Sell 10 Proprietary AI-Developed Fragrance Ingredients In First-of-its-Kind Auction Osmo, the olfactory technology company, announced the first-ever auction of fragrance captives, offering exclusive, perpetual licenses to 10 proprietary molecules developed through its Olfactory Intelligence platform. Launching at the…

Read MoreOsmo to Auction 10 Proprietary AI-Created Fragrance Ingredients
Gurobi

Gurobi Research Team Earns Recognition from Top Scientific Organizations

Gurobi’s Research Leadership Recognized Across Leading Scientific Organizations Gurobi Optimization, LLC, the leader in decision intelligence technology, announced recognitions received by Dr. Edward Rothberg and Dr. Andreas Wächter from leading academic and industry organizations for research that has had lasting…

Read MoreGurobi Research Team Earns Recognition from Top Scientific Organizations